HAVCR2 and cancer: T cells from cancer patients highly express inhibitory receptors including cytotoxicity T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death protein 1 (PD-1), T cell immunoglobulin- and mucin-domain-containing molecule 3 (TIM-3), lymphocyte activation gene 3 (LAG-3), T cell immunoreceptor with Ig and ITIM domains (TIGIT), etc., which contribute to T cell functional exhaustion (5, 6).